PEG-asparaginase in BFM-90 regimen improves outcomes in adults with newly diagnosed lymphoblastic lymphoma

OBJECTIVE: Although L-asparaginase (L-ASP) is a standard treatment for lymphoblastic lymphoma (LBL), hypersensitivity reactions by some patients limit its application. Polyethylene glycol-conjugated asparaginase (PEG-ASP) has a lower immunogenicity and is a standard treatment in all pediatric acute...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Wen, Ren, Hanyun, Ke, Xiaoyan, Xue, Mei, Zhang, Yongqing, Xie, Yan, Lin, Ningjing, Tu, Meifeng, Liu, Weiping, Ping, Lingyan, Ying, Zhitao, Zhang, Chen, Deng, Lijuan, Wang, Xiaopei, Song, Yuqin, Zhu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348477/
https://www.ncbi.nlm.nih.gov/pubmed/28373755
http://dx.doi.org/10.21147/j.issn.1000-9604.2017.01.08

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348477/
https://www.ncbi.nlm.nih.gov/pubmed/28373755
http://dx.doi.org/10.21147/j.issn.1000-9604.2017.01.08

Ejemplares similares